Subtopic Deep Dive
Cytotoxicity Mechanisms of Pyrrolobenzodiazepines
Research Guide
What is Cytotoxicity Mechanisms of Pyrrolobenzodiazepines?
Cytotoxicity mechanisms of pyrrolobenzodiazepines (PBDs) involve sequence-selective DNA minor-groove binding, covalent aminal bond formation at C11 with guanine C2-NH2, and induction of DNA interstrand cross-links leading to cell cycle arrest and apoptosis.
PBDs, including dimers like SJG-136 and SG3199, bind DNA and exert antitumor activity through DNA damage responses (Mantaj et al., 2016; 250 citations). Studies detail structure-activity relationships in harmine derivatives, showing potency against tumor cell lines via DNA binding (Cao et al., 2005; 158 citations). Over 20 papers from 2004-2018 characterize these mechanisms, with clinical insights from phase I trials of SJG-136 (Hochhauser et al., 2009; 78 citations).
Why It Matters
PBD cytotoxicity mechanisms inform antibody-drug conjugate (ADC) design, as in tesirine payloads using SG3199 warhead, improving selectivity in solid tumor therapy (Hartley et al., 2018; 122 citations). Rational modifications enhance potency while reducing neurotoxicity, as shown in harmine derivative SAR analysis against cancer cell lines (Chen et al., 2004; 160 citations). These insights guide next-generation anticancer agents, with SG2285 dimers demonstrating cross-link potency in preclinical models (Hartley et al., 2010; 59 citations).
Key Research Challenges
DNA Repair Inhibition Variability
PBD-induced cross-links trigger variable DNA repair responses across tumor types, complicating efficacy prediction. Hartley et al. (2018) show SG3199 persistence differs in cell lines due to repair enzyme differences. Overcoming this requires SAR data integration (Mantaj et al., 2016).
Structure-Activity Optimization
Correlating C2-aryl substitutions with cytotoxicity potency remains challenging amid neurotoxic risks. SG2285 prodrug design addressed this but highlighted off-target effects (Hartley et al., 2010). Harmine analogs reveal similar trade-offs (Chen et al., 2004).
Clinical Translation Barriers
Phase I trials of SJG-136 identified dose-limiting toxicities despite antitumor activity in solid tumors. Mechanisms like NF-Y inhibition add complexity (Kotecha et al., 2008). Preclinical-to-clinical potency gaps persist (Hochhauser et al., 2009).
Essential Papers
From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)
Julia Mantaj, Paul J. Jackson, Khondaker Miraz Rahman et al. · 2016 · Angewandte Chemie International Edition · 250 citations
Abstract The pyrrolo[2,1‐c][1,4]benzodiazepines (PBDs) are a family of sequence‐selective DNA minor‐groove binding agents that form a covalent aminal bond between their C11‐position and the C2‐NH 2...
Antitumor and neurotoxic effects of novel harmine derivatives and structure‐activity relationship analysis
Qi Chen, Rihui Chao, Hongsheng Chen et al. · 2004 · International Journal of Cancer · 160 citations
Abstract Beta‐carboline alkaloids such as harmine are present in medicinal plants such as Peganum harmala that have been used as folk medicine in anticancer therapy. In our study, 9 harmine derivat...
DNA binding properties of 9-substituted harmine derivatives
Rihui Cao, Wenlie Peng, Hongsheng Chen et al. · 2005 · Biochemical and Biophysical Research Communications · 158 citations
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine
John A. Hartley, Michael Flynn, John P. Bingham et al. · 2018 · Scientific Reports · 122 citations
Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors
Daniel Hochhauser, T Meyer, Victoria J. Spanswick et al. · 2009 · Clinical Cancer Research · 78 citations
Abstract Purpose: This phase I dose-escalation study was undertaken to establish the maximum tolerated dose of the sequence-selective minor groove DNA binding agent SJG-136 in patients with advance...
Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents
Xiaofei Zhang, Rongqin Sun, Yifan Jia et al. · 2016 · Scientific Reports · 65 citations
Abstract A series of novel harmine derivatives bearing a benzylindine substituent in position-1 of β-carboline ring were synthesized and evaluated as antitumor agents. The N2-benzylated β-carboline...
SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity
John A. Hartley, Anzu Hamaguchi, Marissa Coffils et al. · 2010 · Cancer Research · 59 citations
Abstract The pyrrolobenzodiazepines (PBD) are naturally occurring antitumor antibiotics, and a PBD dimer (SJG-136, SG2000) is in phase II trials. Many potent PBDs contain a C2-endo-exo unsaturated ...
Reading Guide
Foundational Papers
Start with Chen et al. (2004; 160 citations) for harmine derivative antitumor SAR, then Cao et al. (2005; 158 citations) for DNA binding properties, followed by Hochhauser et al. (2009; 78 citations) for clinical SJG-136 insights.
Recent Advances
Prioritize Mantaj et al. (2016; 250 citations) for PBD-ADC overview and Hartley et al. (2018; 122 citations) for SG3199 preclinical pharmacology.
Core Methods
DNA minor-groove binding via C11-aminal formation (Hartley et al., 2018); comet assays for cross-links (Hartley et al., 2010); spectrofluorimetry and cell viability MTT assays (Cao et al., 2005).
How PapersFlow Helps You Research Cytotoxicity Mechanisms of Pyrrolobenzodiazepines
Discover & Search
Research Agent uses citationGraph on Mantaj et al. (2016; 250 citations) to map PBD-ADC evolution, then findSimilarPapers for 50+ related cytotoxicity studies. exaSearch queries 'PBD DNA cross-link apoptosis pathways' to uncover harmine derivative mechanisms (Chen et al., 2004).
Analyze & Verify
Analysis Agent applies readPaperContent to Hartley et al. (2018) for SG3199 cell cycle data, then runPythonAnalysis on dose-response curves with NumPy/pandas for IC50 statistics. verifyResponse (CoVe) with GRADE grading confirms DNA binding claims against Cao et al. (2005).
Synthesize & Write
Synthesis Agent detects gaps in NF-Y inhibition for PBD-polyamides (Kotecha et al., 2008), flagging contradictions with ADC data. Writing Agent uses latexEditText and latexSyncCitations for SAR tables, latexCompile for publication-ready reviews, exportMermaid for DNA binding pathway diagrams.
Use Cases
"Analyze IC50 trends in PBD dimer cytotoxicity across tumor lines from Hartley papers"
Research Agent → searchPapers('SG3199 SJG-136 IC50') → Analysis Agent → runPythonAnalysis(pandas plot of dose-responses from readPaperContent) → matplotlib graph of potency correlations.
"Draft LaTeX review of PBD DNA cross-link mechanisms with citations"
Synthesis Agent → gap detection on Mantaj (2016) + Hartley (2018) → Writing Agent → latexEditText(structure) → latexSyncCitations(10 papers) → latexCompile(PDF with SAR figures).
"Find code for PBD binding simulations from related repos"
Research Agent → paperExtractUrls(Hartley 2018) → paperFindGithubRepo(DNA minor groove models) → githubRepoInspect → runPythonAnalysis(adapt simulation for SG3199).
Automated Workflows
Deep Research workflow scans 50+ PBD papers via citationGraph from Chen et al. (2004), generating structured SAR reports with GRADE evidence. DeepScan applies 7-step CoVe to verify cross-link mechanisms in Hartley et al. (2018), checkpointing apoptosis claims. Theorizer hypothesizes novel C2-modifications from dimer data (Hartley et al., 2010).
Frequently Asked Questions
What defines PBD cytotoxicity mechanisms?
PBDs form covalent C11-guanine aminal bonds in DNA minor grooves, creating interstrand cross-links that arrest cell cycle and induce apoptosis (Mantaj et al., 2016).
What methods study PBD DNA interactions?
DNA binding assays, comet assays for cross-links, and flow cytometry for apoptosis/cell cycle effects; harmine derivatives used spectrofluorimetry (Cao et al., 2005).
What are key papers on PBD cytotoxicity?
Mantaj et al. (2016; 250 citations) reviews PBD-ADCs; Hartley et al. (2018; 122 citations) details SG3199 mechanisms; Chen et al. (2004; 160 citations) covers harmine SAR.
What open problems exist in PBD research?
Predicting repair variability across tumors, minimizing neurotoxicity in dimers like SG2285, and translating preclinical potency to clinics as in SJG-136 trials (Hochhauser et al., 2009).
Research Synthesis and pharmacology of benzodiazepine derivatives with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cytotoxicity Mechanisms of Pyrrolobenzodiazepines with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers